Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
78
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

Fabrizia Mariotti1 Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy, [email protected]Correspondence[email protected]
,
Mirco Govoni1 Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy, [email protected]
,
Germano Lucci1 Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy, [email protected]
,
Debora Santoro1 Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy, [email protected]
&
Marie Anna Nandeuil2 Global Clinical Development, Chiesi S.A.S., Courbevoie, France
Pages 3399-3410 | Published online: 18 Oct 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.